Glycopyrrolate as a substitute for atropine in neostigmine reversal of muscle relaxant drugs.
D000758:Anesthesia; D001285:Atropine / Q000494:pharmacology*; D001919:Bradycardia / Q000139:chemically induced; D003472:Curare / Q000037:antagonists & inhibitors*; D004338:Drug Combinations / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006024:Glycopyrrolate / Q000008:administration & dosage / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000494:pharmacology*; D009388:Neostigmine / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013610:Tachycardia / Q000139:chemically induced; D013997:Time Factors
D004338:Drug Combinations; D008333:Mandelic Acids; D010276:Parasympatholytics; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D009388:Neostigmine; D001285:Atropine; D003472:Curare; D006024:Glycopyrrolate